StonvexLoading…
StonvexStonvexStonvexCore line items from MGNI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $164.37M | $713.95M | $508.60M | $329.10M |
Operating Income | $7.72M | $97.60M | $45.64M | $20.59M |
Net Income | $4.41M | $144.61M | $21.56M | $11.14M |
EPS (Diluted) | $0.03 | $0.95 | $0.14 | $0.01 |
Total Assets | $2.95B | $3.16B | $2.92B | $2.93B |
Total Liabilities | $2.03B | $2.24B | $2.11B | $2.16B |
Cash & Equivalents | $184.65M | $553.36M | $482.13M | $426.00M |
Free Cash Flow OCF − CapEx | $-130.17M | $165.63M | $62.58M | $-5.80M |
Shares Outstanding | 143.30M | 142.96M | 143.64M | 142.38M |